Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750320 · ClinicalTrials.gov registry record · Phase 1
Koning Breast Computed Tomography Guided Biopsy
A Phase 1 study of Breast Cancer, sponsored by Koning Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT01750320: Completed Phase 1 study of Breast Cancer, sponsored by Koning Corporation.
NCT01750320 is a Phase 1 study of Breast Cancer that has completed, run by Koning Corporation. The registered enrollment target is 4 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01750320, a Phase 1 study of Breast Cancer, has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to show that the accuracy of Koning Breast CT-guided biopsy is at least equivalent to that of stereotactic-guided biopsy.
Primary Outcome
The goal of this study is to evaluate the concordance of Koning Breast CT-guided Biopsy (KBCT-GBx) results to diagnostic work-up imaging (at least mammographic) and KBCT imaging and to verify that the localization and guidance accuracy of KBCT-GBx is at least equivalent to stereotactic-guided biopsy to validate the localization and guidance accuracy of KBCT-GBx.
Conditions Studied
Interventions
- DEVICE Koning Breast CT-guided Biopsy
Study Locations (1)
New York
- Elizabeth Wende Breast Care - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
What the finished NCT01750320 record still lists
NCT01750320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Koning Breast CT-guided Biopsy is the first listed.
NCT01750320 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01750320 about?
NCT01750320 is a clinical study titled "Koning Breast Computed Tomography Guided Biopsy". The primary aim of this study is to show that the accuracy of Koning Breast CT-guided biopsy is at least equivalent to that of stereotactic-guided biopsy.
What is the current status of trial NCT01750320?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2012-08. Estimated completion is 2015-12.
What conditions does trial NCT01750320 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01750320?
The interventions under investigation include: Koning Breast CT-guided Biopsy (DEVICE).
Who is sponsoring clinical trial NCT01750320?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01750320 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01750320's enrollment target sits among peer trials
4 1215th of 1224 higher than 9 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VS-6766+Abema+Fulv in Met HR+/HER- BC
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia